関連する実験動画
Updated: Jul 14, 2026

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
高齢者における胃酸性
A Hurwitz1, D A Brady, S E Schaal
1Department of Medicine, University of Kansas Medical Center, Kansas City 66160-7320, USA. ahurwitz@kumc.edu
JAMA
|August 27, 1997
まとめ
ほとんどの高齢者は胃酸を保ち,以前の信念に異議を唱える. 一部の高齢者の低酸性は,縮性胃炎と関連しており,さらなる研究が必要であることを示しています.
科学分野:
- 胃腸内科 胃腸内科
- ゲリアトリクス ゲリアトリクス
- 内科内科は,内科の内科である.
背景:
- 従来の知恵は,年齢とともに胃酸度が低下することを示唆していました.
- しかし,高齢者におけるアクロヒドリアの続発の稀さは,この概念に疑問を投げかけました.
研究 の 目的:
- 高齢者における基礎胃酸の有病率を決定する.
- この集団における血清ペプシノゲン比率を用いて,縮性胃炎の流行を評価する.
主な方法:
- 248人の独立した高齢のボランティア (65歳以上) を対象とした横断的な研究です.
- キニニウム樹脂を用いた基礎胃酸分泌の非侵襲的評価.
- 血清ペプシノゲンI/II比 (<2.9) に基づくアトロフィック胃炎の診断
主要な成果:
- 84%の被験者が基礎状態で胃酸含有量 (pH <3.5) を示した.
- 罹患率の推定値:67%一貫した酸分泌,22%断続的,11%一貫して高いpH.
- 一貫した低分泌体 (低酸性) は,酸分泌体 (5%) と比較して,縮性胃炎 (67%) の高い流行を示しました.
結論:
- 一般的な考えに反して,ほとんどの高齢者は胃酸の分泌能力を保持しています.
- 高齢者の低胃酸は,アトロフィック性胃炎と有意に関連しています.
- 研究結果は,年齢に関係する胃酸性低下の再評価が正当であることを示唆しています.
関連する概念動画
Stomach pH Regulation
The human body carefully regulates the internal pH of different organs to maintain homeostasis. For example, while the blood plasma maintains a neutral pH of 7, the stomach lumen has an acidic pH of 1.5 - 3.5. The low pH of stomach lumen helps kill pathogens in the food and break down complex food molecules.
The acid-secreting gastric mucosal epithelial cells (parietal cells) lining the stomach lumen maintain the low pH in the lumen. Numerous ion transporters and channels on these parietal...
The acid-secreting gastric mucosal epithelial cells (parietal cells) lining the stomach lumen maintain the low pH in the lumen. Numerous ion transporters and channels on these parietal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

